Eterna Therapeutics
ERNA
ERNA
38 hedge funds and large institutions have $2.44M invested in Eterna Therapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
57% less capital invested
Capital invested by funds: $5.66M → $2.44M (-$3.21M)
Holders
38
Holding in Top 10
–
Calls
$42K
Puts
$11K
Top Buyers
| 1 | +$604K | |
| 2 | +$126K | |
| 3 | +$60.1K | |
| 4 |
VF
Virtu Financial
New York
|
+$16K |
| 5 |
Man Group
London,
United Kingdom
|
+$10K |
Top Sellers
| 1 | -$977K | |
| 2 | -$814K | |
| 3 | -$798K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$176K |
| 5 |
BlackRock
New York
|
-$136K |